Php316 - Exploring Biosimilar Market Access Considerations Across the Eu

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1210
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pnd110 - Gene Therapy Products – Market Access Situation in Eu and in Slovakia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

An Overview of the Biosimilar Market in the Us

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Market Access of Implantable Medical Devices: Evidentiary Requirements Across Global Markets

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Reinvigorating the EU Single Market

OECD Economics Department Working Papers
2014English

Exploring Brexit With Dynamic Spatial Panel Models: Some Possible Outcomes for Employment Across the EU Regions

Annals of Regional Science
Social SciencesEnvironmental Science
2019English

Growing Export Performance of Transition Economies: EU Market Access Versus Supply Capacity Factors

SSRN Electronic Journal
2008English

Exploring the Duration of EU Imports

Review of World Economics
EconomicsEconometricsFinance
2011English

First Biosimilar Drug Set to Enter US Market

Nature
Multidisciplinary
2015English

Early Market Access for Pharmaceuticals in EU: What Is the Impact of Ema’s Accelerated Assessment Procedure?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy